↓ Skip to main content

EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells

Overview of attention for article published in BMC Cancer, December 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
28 Mendeley